Alexandra Hanlon1, William Small, Jonathan Strauss, Lilie L Lin, Laura Hanisch, Liming Huang, Jinbing Bai, Jessica Wells, Deborah Watkins Bruner. 1. Author Affiliations: School of Nursing (Drs Hanlon and Huang) and Department of Radiation Oncology (Dr Lin), University of Pennsylvania, Philadelphia; FASTRO Department of Radiation Oncology, Loyola University (Dr Small); and Department of Radiation Oncology, Northwestern University (Dr Strauss), Chicago, Illinois; National Comprehensive Cancer Network, Fort Washington, Pennsylvania (Dr Hanisch); and Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia (Drs Bai, Wells, and Bruner).
Abstract
BACKGROUND:Vaginal brachytherapy, a common treatment of endometrial cancer, is associated with high rates of vaginal stenosis. Recommendations for vaginal dilator use to minimize stenosis generally include 3 times per week for approximately 10 minutes per use. However, adherence rates range widely and are generally well less than 50%. OBJECTIVES: The aims of this study were to assess feasibility of recruitment to a study of dilator use and test a theoretically driven enhanced educational program (EEP) to increase adherence. METHODS: Eligibility included women treated with postoperative vaginal brachytherapy for stage I to IIIc endometrial cancer. Patients were randomized to either nurse-delivered standard institutional instruction or EEP. RESULTS: Of eligible patients, 76% consented, 42 were randomized, and 69% completed the 6-month assessment. Mean age was 58.2 years; 48% were sexually active. There was no difference in adherence between arms. Overall, 20% and 8.3% were adherent to the prescribed use of 3 times per week, and 64% and 16% were adherent to use at least once per week at 6 weeks and 6 months, respectively. Adherence was greater among those motivated by vaginal health and having lower body mass index. Nonadherence was significantly higher among those who are college educated, in the EEP group, and with higher weight. CONCLUSIONS: Feasibility of recruitment into a study of vaginal dilator use was high. Adherence was low, and there was no difference between groups. Adherence to vaginal dilator use requires novel interventions to test. IMPLICATIONS FOR PRACTICE: Nursing education that includes how dilators may maintain vaginal health may improve use because it was a motivator for adherence in this study.
RCT Entities:
BACKGROUND: Vaginal brachytherapy, a common treatment of endometrial cancer, is associated with high rates of vaginal stenosis. Recommendations for vaginal dilator use to minimize stenosis generally include 3 times per week for approximately 10 minutes per use. However, adherence rates range widely and are generally well less than 50%. OBJECTIVES: The aims of this study were to assess feasibility of recruitment to a study of dilator use and test a theoretically driven enhanced educational program (EEP) to increase adherence. METHODS: Eligibility included women treated with postoperative vaginal brachytherapy for stage I to IIIc endometrial cancer. Patients were randomized to either nurse-delivered standard institutional instruction or EEP. RESULTS: Of eligible patients, 76% consented, 42 were randomized, and 69% completed the 6-month assessment. Mean age was 58.2 years; 48% were sexually active. There was no difference in adherence between arms. Overall, 20% and 8.3% were adherent to the prescribed use of 3 times per week, and 64% and 16% were adherent to use at least once per week at 6 weeks and 6 months, respectively. Adherence was greater among those motivated by vaginal health and having lower body mass index. Nonadherence was significantly higher among those who are college educated, in the EEP group, and with higher weight. CONCLUSIONS: Feasibility of recruitment into a study of vaginal dilator use was high. Adherence was low, and there was no difference between groups. Adherence to vaginal dilator use requires novel interventions to test. IMPLICATIONS FOR PRACTICE: Nursing education that includes how dilators may maintain vaginal health may improve use because it was a motivator for adherence in this study.
Authors: William Small; Sushil Beriwal; D Jeffrey Demanes; Kathryn E Dusenbery; Patricia Eifel; Beth Erickson; Ellen Jones; Jason J Rownd; Jennifer F De Los Santos; Akila N Viswanathan; David Gaffney Journal: Brachytherapy Date: 2012 Jan-Feb Impact factor: 2.362
Authors: Rinske M Bakker; Willemijn M Vermeer; Carien L Creutzberg; Jan Willem M Mens; Remi A Nout; Moniek M Ter Kuile Journal: J Sex Med Date: 2014-11-25 Impact factor: 3.802
Authors: Eleonora Poggiogalle; Luca Di Lazzaro; Alessandro Pinto; Silvia Migliaccio; Andrea Lenzi; Lorenzo M Donini Journal: Int J Endocrinol Date: 2014-02-23 Impact factor: 3.257
Authors: John M Stahl; Jack M Qian; Christopher J Tien; David J Carlson; Zhe Chen; Elena S Ratner; Henry S Park; Shari Damast Journal: Support Care Cancer Date: 2018-09-05 Impact factor: 3.603
Authors: Adrianna Wierzbicka; Dorota Mańkowska-Wierzbicka; Stanisław Cieślewicz; Marta Stelmach-Mardas; Marcin Mardas Journal: Int J Environ Res Public Health Date: 2021-04-08 Impact factor: 3.390
Authors: Emily Flower; Salman Zanjani; Gemma Busuttil; Emma Sullivan; Wayne Smith; Kathy Tran; David Thwaites; Jennifer Chard; Viet Do Journal: J Contemp Brachytherapy Date: 2021-12-30
Authors: Vitaliana De Sanctis; Daniela Musio; Francesca De Felice; Francesco Marampon; Maurizio Valeriani; Paolo Bonome; Dimitri Anzellini; Giuseppe Facondo; Gianluca Vullo; Maria Massaro; Mario Di Staso; Pierluigi Bonfili; Agnieszka Chalaszczyk; Giovanni Luca Gravina; Vincenzo Tombolini; Mattia Falchetto Osti Journal: J Contemp Brachytherapy Date: 2020-04-30